Corbus gets green light to begin pivotal trial of ADC for oropharyngeal cancer — See source for full details.
$CRBP
Price history, market instrument context, member research, and related headlines in one place.
CRBP key statistics
NasdaqCMUSD
52-week range
$4.231%$20.56
Latest session $4.23–$4.62Corbus Pharmaceuticals Holdings, Inc. (CRBP) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $4.33, down $0.08 (1.81%) from the previous close of $4.41. It has traded between $4.23 and $4.62 in the latest session. Over the past year it has ranged from $4.23 to $20.56, leaving it trading near the bottom of its 52-week range. Reported volume for the session was 1.1M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Form 144 Corbus Pharmaceuticals Holdings For: 27 July — See source for full details.
Loading $CRBP research…